Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)
Camp4 Therapeutics recorded quarterly Research & Development of $10.2 million in Q1 2026, up 134.27% quarter-over-quarter from -$29.6 million in Q4 2025, and little changed year-over-year from $10.1 million in Q1 2025.
Camp4 Therapeutics' Research & Development history runs 4 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- In Q1 2026, Research & Development changed 0.14% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $214000.0 (down 99.45% YoY), while the FY2025 annual figure was $200000.0, down 99.48% from the prior year.
- Research & Development came in at $10.2 million for Q1 2026 at Camp4 Therapeutics, up from -$29.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $10.7 million in Q4 2023 to a low of -$29.6 million in Q4 2025.
- A 4-year average of $6.3 million and a median of $9.8 million in 2023 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 10.16% in 2025 and fell as far as 396.57% in 2025.
- Camp4 Therapeutics' Research & Development stood at $10.7 million in 2023, then declined by 6.24% to $10.0 million in 2024, then sank by 396.57% to -$29.6 million in 2025, then soared by 134.27% to $10.2 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $10.2 million, -$29.6 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 10.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16 Mn |
| Dec 31, 2025 | -29.65 Mn |
| Sep 30, 2025 | 9.36 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 10.15 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 9.39 Mn |
| Mar 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 9.82 Mn |